Ranked in 2 Practice Areas
3

Band 3

4

Band 4

Intellectual Property: Patent Litigation

London (Firms)

3 Years Ranked

About

Provided by Jennifer Antcliff

UK

Practice Areas

Jenny is a partner in the firm’s Dispute Resolution team, ranked as a Next Generation Partner by Legal 500 (2022) and an Up and Coming Partner by Chambers & Partners (2022). Her patent litigation expertise focusses on biotechnology and pharmaceutical products, including blockbuster small molecule drugs, therapeutic antibodies and orphan medicines. According to Legal 500 (2022), Jenny is “one of the best patent litigators in London”.

Jenny has litigated before the UK Patents Court, the Court of Appeal and the Supreme Court, most notably the Eli Lilly v Human Genome Sciences cases, and the Warner-Lambert v Actavis (“pregabalin”) litigation. Jenny has since represented FibroGen against Akebia in a further significant and successful appeal to test the boundaries of UK law on sufficiency (Impact Case of the Year, MIP 2022).

Jenny also specialises in complex SPC litigation and associated regulatory advice, many cases involving references to the CJEU or EFTA Court, including C-493/12 Eli Lilly v Human Genome Sciences, E-16/14 Pharmaq v Intervet, C-577/13 Actavis v Boehringer Ingelheim, C-443/17 AbraxisBioscience and, most recently, Teva v Janssen Pharmaceutica (Xeplion®). Jenny was awarded SPC Litigator of the Year at the LMG Life Sciences Awards (EMEA) in 2023 and 2022.

As a “highly skilled patent litigator with an extensive knowledge of the pharmaceutical industry” (Chambers & Partners, 2022) Jenny increasingly assists her clients in this sector with cross-border patent and SPC litigation matters, working closely with the business and external advisers to align launch or enforcement strategies across Europe.

Career

Jenny joined Carpmaels & Ransford from her role as IP Litigation Counsel at Actavis/Allergan, where she handled high-profile patent cases such as Actavis v ICOS (tadalafil) and the LYRICA® (pregabalin) litigation – the first case before the UK Courts in which infringement of a second medical use patent was put in issue. Actavis successfully resisted an interim injunction and any findings of infringement at trial.

Jenny trained and qualified at a magic circle firm after obtaining а first class honours degree in biochemistry from Imperial College, London, and а doctorate in molecular and structural biology from the University of Oxford.

Chambers Review

Provided by Chambers

UK

Life Sciences: IP/Patent Litigation - UK-wide
3
Band 3

Jennifer Antcliff has a strong patent litigation practice, and is regularly instructed to act by major clients in the life sciences space.


Intellectual Property: Patent Litigation - London (Firms)
4
Band 4

Jennifer Antcliff is recommended for her coordination and litigation of patent litigation in the life sciences sector. In addition to representing clients on patents disputes, she also advises them on patent enforcement strategies.

Strengths

Provided by Chambers

Discover other Lawyers at
Carpmaels & Ransford LLP

Provided by Chambers
Filter by
Band

London (Firms)

Intellectual Property

Ian Kirby
3
Ian Kirby
3
Band 3
Intellectual Property: Patent Litigation

David Wilson
3
David Wilson
3
Band 3
Ian Kirby
3
Ian Kirby
3
Band 3
Camilla Balleny
4
Camilla Balleny
4
Band 4
Jennifer Antcliff
4
Jennifer Antcliff
4
Band 4

UK-wide

Intellectual Property: Patent Attorneys

E
Hugh Goodfellow
E
Eminent Practitioners
Cameron Marshall
1
Cameron Marshall
1
Band 1
1
Chris Hoggett
1
Band 1
Life Sciences: IP/Patent Litigation

David Wilson
3
David Wilson
3
Band 3
Jennifer Antcliff
3
Jennifer Antcliff
3
Band 3